Spaces:
Running
Running
| PRIMO is an open benchmark, and it is **deliberately incomplete**. The **Boards** | |
| page shows exactly how far it reaches today, the live boards, and names the | |
| gaps as open cards. Everything past that still needs somebody to bring it. | |
| PRIMO was started by **Scienta Lab**. The intent is community governance; how | |
| that actually works is part of what the first partners will define. | |
| ## Add a cohort | |
| PRIMO has no shortage of models. What is hard to find is **an omics cohort with | |
| patient-level clinical labels**, whether that is drug response, a severity score | |
| or a molecular subtype. If you hold one, or know a group that does, tell us: | |
| - **modality** and roughly how many patients | |
| - **what is labelled**, and how many patients carry that label | |
| - **disease and tissue** | |
| - **licence**, and whether the data can be redistributed | |
| [Propose a cohort](mailto:karim.elkanbi@scientalab.com?subject=PRIMO%20cohort%20proposal&body=Modality%20and%20rough%20patient%20count%3A%0A%0AWhat%20is%20labelled%2C%20and%20how%20many%20patients%20carry%20that%20label%3A%0A%0ADisease%20and%20tissue%3A%0A%0ALicence%2C%20and%20whether%20the%20data%20can%20be%20redistributed%3A%0A) | |
| There is no formal acceptance process yet. We are writing it with the first | |
| partners, and we would rather admit that than invent rules nobody has agreed to. | |
| What you will get today is a real answer and a technical conversation. | |
| ## Add a task, without bringing any data | |
| This one costs you nothing but an idea. Ask **a better question of the cohorts | |
| already here**: a label we are not predicting, a transfer split nobody has tried, | |
| or a metric that would say more than the one we use. Methodology counts here as | |
| much as data does. | |
| [Propose a task](mailto:karim.elkanbi@scientalab.com?subject=PRIMO%20task%20proposal&body=Task%20I%20would%20add%3A%0A%0AWhich%20cohorts%20already%20in%20PRIMO%20it%20uses%3A%0A%0AWhat%20is%20predicted%2C%20and%20with%20which%20metric%3A%0A%0AWhy%20it%20says%20something%20the%20current%20tasks%20do%20not%3A%0A) | |
| ## Add a modality or a therapeutic area | |
| The **OPEN** cards on the Boards page mark the omics layers and clinical areas | |
| PRIMO does not reach yet. Read them as gaps waiting for someone rather than as a roadmap we | |
| are already working through. Opening one takes a single cohort with clinical | |
| labels, and not a whole atlas. | |
| [Claim an open board](mailto:karim.elkanbi@scientalab.com?subject=PRIMO%20open%20board&body=Board%20I%20want%20to%20open%3A%0A%0AWhat%20I%20can%20bring%20%28cohort%2C%20labels%2C%20licence%29%3A%0A) | |
| ## Become a founding partner | |
| Founding partners shape PRIMO rather than just appear on it: a voice on the | |
| methodology, co-signature on what we publish, and early access to the results. | |
| [Talk to us about partnership](mailto:karim.elkanbi@scientalab.com?subject=PRIMO%20founding%20partner&body=Organisation%3A%0A%0AWhat%20we%20would%20bring%20to%20PRIMO%3A%0A%0AWhat%20we%20would%20want%20from%20it%3A%0A) | |
| · [primomics.org](http://primomics.org/) | |
| ## Smaller ways in | |
| - **Question the method.** Open a thread in the Space's **Community** tab. | |
| - **Submit a model.** Baselines are on the leaderboard already; beat them. | |
| - **Read the paper**: [OpenReview](https://openreview.net/forum?id=v2SA8gHwqo) | |
| - **Look at the data**: [PRIMOmics/primo](https://huggingface.co/datasets/PRIMOmics/primo) | |